secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regenerative Medical Technology Group Inc. (RMTG)
CIK:        0001760026
Form:       8-K/A
Filed at:   2022-03-23T23:59:59+00:00
Accession:  0001213900-22-014379
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.01, 1.01, 3.02, 5.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Meso Numismatics completes acquisition of Global Stem Cells Group; financials show $105K net loss
--------------------------------------------------------------------------------

- Acquisition closed Aug 18, 2021: Meso Numismatics acquires GCSC for 1M Series AA pref, 8,974 Series DD pref, and $225K.
- Change in control: Benito Novas receives Series AA super-voting stock (67% aggregate vote); CEO Christensen holds 50K Series AA.
- GCSC's audited financials: 2020 revenue $615K (down from $1.02M in 2019), net loss $105K; $461K cash, $459K liabilities.
- Going concern opinion: GCSC has recurring losses and working capital deficit, raising substantial doubt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760026/000121390022014379/0001213900-22-014379-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760026/000121390022014379/ea157183-8ka1_meso.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-014379

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer